AGIO

AGIO

USD

Agios Pharmaceuticals Inc. Common Stock

$39.440+0.110 (0.280%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$39.330

Máximo

$40.320

Mínimo

$38.900

Volume

0.19M

Fundamentos da empresa

Capitalização de mercado

2.3B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.65M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $23.42Atual $39.440Máximo $62.58

Notícias relacionadas

GlobeNewswire

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases,

Ver mais
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
GlobeNewswire

Agios Reports Third Quarter 2025 Financial Results and Provides Business Update

$12.9 million in third quarter PYRUKYND® (mitapivat) net revenuesPDUFA goal date for PYRUKYND U.S. sNDA in thalassemia set for December 7, 2025CHMP adopted positive opinion for PYRUKYND in thalassemia; EC decision

Ver mais
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update